HER2 testing in gastric and esophageal adenocarcinoma: new diagnostic challenges arising from new therapeutic options

Author： Koltz BR   Hicks DG   Whitney-Miller CL  

Publisher： Informa Healthcare

ISSN： 1473-7760

Source： Biotechnic & Histochemistry, Vol.87, Iss.1, 2012-01, pp. : 40-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The evolving role of HER2 evaluation for diagnosis and clinical decision making for breast and gastric adenocarcinoma

By Hicks DG   Whitney-Miller CL  

Biotechnic & Histochemistry, Vol. 88, Iss. 3-4, 2013-05 ,pp. : 121-131

Informa Healthcare

Access to resources Recommend Favorite

New Useful Options in Anesthesiological Monitoring

By Levite E.   Bobrinskaya I.  

Biomedical Engineering, Vol. 39, Iss. 4, 2005-07 ,pp. : 203-204

Springer Publishing Company

Access to resources Recommend Favorite

From human genes to stem cells: new challenges for patent law?

By Caulfield T.A.  

Trends in Biotechnology, Vol. 21, Iss. 3, 2003-03 ,pp. : 101-103

Elsevier

Access to resources Recommend Favorite

A new era in pyrogen testing

By Ding J.L.   Ho B.  

Trends in Biotechnology, Vol. 19, Iss. 8, 2001-08 ,pp. : 277-281

Elsevier

Access to resources Recommend Favorite

Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung

By Ye J   Hameed O   Findeis-Hosey JJ   Fan L   Li F   McMahon LA   Yang Q   Wang HL   Xu H  

Biotechnic & Histochemistry, Vol. 87, Iss. 1, 2012-01 ,pp. : 30-34

Informa Healthcare

Access to resources Recommend Favorite